Pharmaceutical Technology

MARCH 24, 2023

Biosimilars are an important tool to facilitate competition, lower the price of drugs, and create savings across the board. Until 2010, no regulatory approval pathway for biosimilars existed in the US and the first biosimilar was only approved in the US in 2015. For example, AbbVie had obtained more than 100 patents for Humira.

Competition 59

Competition Marketing FDA Physicians 59

PM360

JUNE 11, 2022

This article will explore how life sciences marketers can increase their competitive advantage by applying the discipline’s basic principles to their own strategies. In terms of branding, this judo principle lies at the nexus of three interrelated concepts: market research, competitive analysis, and brand positioning.

Marketing 52

Marketing Competition Pharma Manufacturing 52

PM360

NOVEMBER 29, 2022

1 And, on average , the FDA approved 60% more drugs between 2010-2019 than the yearly average over the previous decade. NSF, “Pharma Pipeline at an All-Time High,” from Informa Pharma R&D Annual Review 2022 (May 2022). The global pool of investigators is growing on average between 3.3-5.6% Reference: 1. See resource here.

Medical science 95

Medical science Medical Customer Relationship Management Doctors 95

Clarivate

APRIL 18, 2024

Humana is following a similar growth strategy as it sharpens competition with UnitedHealthcare in the Medicare Advantage sector. Signify’s healthcare platform also assists 65,000 provider partners to participate in value-based care with nearly 1 million attributed lives Oak Street Health acquisition May 2023 CVS acquired Oak Street for $10.6

Retail 52

Retail Healthcare Healthcare Physicians 52

Evolve Your Success

MAY 16, 2023

It’s organizations like Medasic that are a group of physicians and nurses that have their hearts in the right place that are trying to help patients get off of these drugs and have a better life. I remember back in my pharmaceutical sales rep days and I’m talking as far as 2009 or 2010. It blew back in the pharma companies.

Medical sales 52

Medical sales Sales Medical Doctors 52

Pharmaceutical Technology

OCTOBER 25, 2022

Understanding both the significant competitive advantages that FDC products can offer, and the difficulties and potential pitfalls associated with development and manufacturing of FDC drugs in oral solid dosage forms is a critical first step for companies exploring this approach. More FDC products flowing into pharma pipelines.

Manufacturing 52

Manufacturing Physicians Prescription FDA 52

Pharmaceutical Technology

DECEMBER 4, 2022

Others are made by big pharma giants like Boehringer Ingelheim , Novartis , or Pfizer , which has raised the expectations for a competitive market. . Even some physicians remain hesitant about biosimilars in general. There are seven FDA-approved Humira biosimilars, of which Amgen’s Amjevita will be launched in January.

Marketing 104

Marketing Physicians Competition Patients 104